Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02799602 |
|---|---|
| Brief Title: | Darolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer (ARASENS) |
| First Submitted : | June 6, 2016 |
| First Submitted that Met QC Criteria : | June 10, 2016 |
| First Posted : | June 15, 2016 (Estimate) |
| Results First Submitted : | October 25, 2022 |
| Results First Submitted that Met QC Criteria : | January 29, 2023 |
| Results First Posted : | February 24, 2023 |
| Last Update Submitted that Met QC Criteria : | March 24, 2024 |
| Last Update Posted : | April 16, 2024 |